BRL 37344 sodium

Research use only, not for human use.

BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.

BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively; A potent agonist in brown adipocytes (EC50 = 3.3 +/- 0.8 nM) than in white adipocytes (EC50=5.7 nM) or colon (EC50=27.5 nM); Stimulates fuel oxidation by soleus muscle in vitro.Diabetes Discontinued

BRL37344 sodium

Angiogenesis

Adrenergic Receptor

Adrenergic Receptor

Metabolic Disease

Diabetes

127299-93-8

385.82

C19H21NO4ClNa

>98% (HPLC)

——

CC(CC1=CC=C(C=C1)OCC(=O)[O-])NCC(C2=CC(=CC=C2)Cl)O.[Na+]

Rel-2-[4-[(2S)-2-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]-acetic acid, monosodium salt

(-20℃)

With Ice Pack

≥ 2 years